Annual Total Long Term Liabilities
$4.19 M
-$1.00 M-19.25%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual total long term liabilities is $4.19 million, with the most recent change of -$1.00 million (-19.25%) on December 31, 2023.
- During the last 3 years, PBLA annual total long term liabilities has risen by +$4.19 million (+100.00%).
- PBLA annual total long term liabilities is now -19.25% below its all-time high of $5.19 million, reached on December 31, 2022.
Performance
PBLA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$3.19 M
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly total long term liabilities is $3.19 million, unchanged on September 30, 2024.
- Over the past year, PBLA quarterly long term liabilities has dropped by -$1.00 million (-23.84%).
- PBLA quarterly long term liabilities is now -38.51% below its all-time high of $5.19 million, reached on June 30, 2022.
Performance
PBLA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PBLA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | -23.8% |
| 3 y3 years | +100.0% | -23.8% |
| 5 y5 years | +100.0% | -23.8% |
PBLA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.3% | -100.0% | -38.5% | -100.0% |
| 5 y | 5-year | -19.3% | -100.0% | -38.5% | -100.0% |
| alltime | all time | -19.3% | -100.0% | -38.5% | -100.0% |
Panbela Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.19 M(0.0%) |
| Jun 2024 | - | $3.19 M(0.0%) |
| Mar 2024 | - | $3.19 M(-23.8%) |
| Dec 2023 | $4.19 M(-19.3%) | $4.19 M(0.0%) |
| Sep 2023 | - | $4.19 M(0.0%) |
| Jun 2023 | - | $4.19 M(0.0%) |
| Mar 2023 | - | $4.19 M(-19.3%) |
| Dec 2022 | $5.19 M(>+9900.0%) | $5.19 M(0.0%) |
| Sep 2022 | - | $5.19 M(0.0%) |
| Jun 2022 | - | $5.19 M(>+9900.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(-100.0%) |
| Jun 2020 | - | $1000.00(>+9900.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2019 | - | $742.00 K(0.0%) |
| Jun 2019 | - | $742.00 K(>+9900.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(-100.0%) |
| Mar 2018 | - | $250.00 K(-12.6%) |
| Dec 2017 | $286.00 K(>+9900.0%) | $286.00 K(-80.7%) |
| Sep 2017 | - | $1.48 M(+107.4%) |
| Jun 2017 | - | $715.00 K(+189.5%) |
| Mar 2017 | - | $247.00 K(>+9900.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $3.07 M(+0.4%) |
| Jun 2016 | - | $3.06 M(+0.3%) |
| Mar 2016 | - | $3.05 M(+0.3%) |
| Dec 2015 | $3.04 M(-8.7%) | $3.04 M(-2.3%) |
| Sep 2015 | - | $3.11 M(>+9900.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(-100.0%) |
| Dec 2014 | $3.33 M(>+9900.0%) | $3.33 M(>+9900.0%) |
| Sep 2014 | - | $3600.00(+12.5%) |
| Jun 2014 | - | $3200.00(-33.3%) |
| Mar 2014 | - | $4800.00(-26.2%) |
| Dec 2013 | $6500.00(-20.7%) | $6500.00(+1.6%) |
| Sep 2013 | - | $6400.00(-19.0%) |
| Jun 2013 | - | $7900.00(+16.2%) |
| Mar 2013 | - | $6800.00(-17.1%) |
| Dec 2012 | $8200.00(+115.8%) | $8200.00 |
| Dec 2011 | $3800.00 | - |
FAQ
- What is Panbela Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Panbela Therapeutics?
- What is Panbela Therapeutics annual total long term liabilities year-on-year change?
- What is Panbela Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly long term liabilities year-on-year change?
What is Panbela Therapeutics annual total long term liabilities?
The current annual total long term liabilities of PBLA is $4.19 M
What is the all time high annual total long term liabilities for Panbela Therapeutics?
Panbela Therapeutics all-time high annual total long term liabilities is $5.19 M
What is Panbela Therapeutics annual total long term liabilities year-on-year change?
Over the past year, PBLA annual total long term liabilities has changed by -$1.00 M (-19.25%)
What is Panbela Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of PBLA is $3.19 M
What is the all time high quarterly long term liabilities for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly total long term liabilities is $5.19 M
What is Panbela Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, PBLA quarterly total long term liabilities has changed by -$1.00 M (-23.84%)